Yasar B, Suh YE, Chapman E, Nicholls L, et al. 2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2026 Jan 11:S0360-3016(26)00019.
PMID: 41529792